Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging

被引：8

作者：

Mertens, Koen ^{[1
]}

Acou, Marjan ^{[2
]}

Van den Broecke, Caroline ^{[3
]}

Nuyts, Roel ^{[4
]}

Van Roost, Dirk ^{[4
]}

Achten, Eric ^{[2
]}

Goethals, Ingeborg ^{[1
]}

机构：

[1] Ghent Univ Hosp, Dept Nucl Med, Med Poliklin 7, B-9000 Ghent, Belgium

[2] Ghent Univ Hosp, Dept Radiol, B-9000 Ghent, Belgium

[3] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium

[4] Ghent Univ Hosp, Dept Neurosurg, B-9000 Ghent, Belgium

来源：

JOURNAL OF CLINICAL NEUROSCIENCE | 2012年 / 19卷 / 08期

关键词：

Delayed imaging; F-18; fluorodeoxyglucose; Positron emission tomography; Progressive multifocal leukoencephalopathy; POSITRON-EMISSION-TOMOGRAPHY; BRAIN-LESIONS; SPECTROSCOPY; AIDS;

D O I：

10.1016/j.jocn.2011.08.043

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The purpose of our study was to determine the increase in F-18 fluorodeoxyglucose (FDG) uptake in a patient with progressive multifocal leukoencephalopathy (PML) between early and late scan times using positron emission tomography (PET) imaging with F-18 FDG at conventional (60 minutes (mini after injection. PET60) and delayed (300 min after injection, PET300) intervals. PET60 and PET300 imaging was performed on a pathologically proven PML lesion. The PML lesion in the posterior fossa exhibited an increase in F-18 FDG uptake of 52% between early and late times, which was in the range of that in high-grade gliomas. Thus, dual-time-point PET with F-18 FDG may not be able to differentiate between infectious and malignant brain lesions. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：1167 / 1169

页数：3

共 50 条

[21] Benign F-18 FDG uptake along a mediastinoscopy tract - Demonstration by F-18 FDG PET/CT imaging
Roarke, Michael C.
CLINICAL NUCLEAR MEDICINE, 2008, 33 (09) : 649 - 650
[22] F-18 FDG PET imaging of fibrolamellar hepatocellular carcinoma
von Falck, Christian
Rodt, Thomas
Shin, Hoen-oh
Knapp, Wolfram H.
Galanski, Michael
CLINICAL NUCLEAR MEDICINE, 2008, 33 (09) : 633 - 634
[23] Superiority of F-18 FDG PET imaging for detection of a pheochromocytoma
Sood, R
Story, A
Rossleigh, MA
Haindl, W
Guille, J
Pillai, D
CLINICAL NUCLEAR MEDICINE, 2006, 31 (01) : 13 - 15
[24] F-18 FDG PET/CT Imaging of a Parapharyngeal Hemangioma
Surasi, Devaki S.
Meibom, Sara
Grillone, Gregory
Subramaniam, Rathan M.
CLINICAL NUCLEAR MEDICINE, 2010, 35 (08) : 612 - 613
[25] F-18 FDG PET imaging in gastrointestinal stromal tumor
Reddy, MP
Reddy, P
Lilien, DL
CLINICAL NUCLEAR MEDICINE, 2003, 28 (08) : 677 - 679
[26] F-18 FDG-PET Imaging in Rectal Leiomyoma
Watanabe, Naoto
Taniguchi, Mitsuru
Takahashi, Tomoko
Doai, Mariko
Funada, Hisashi
Seto, Hikaru
Tonami, Hisao
CLINICAL NUCLEAR MEDICINE, 2010, 35 (05) : 374 - 375
[27] F-18 FDG PET/CT Imaging of Intraventricular Germinoma
Yu, Chih-Hsiang B.
Peller, Patrick J.
Subramaniam, Rathan
CLINICAL NUCLEAR MEDICINE, 2009, 34 (06) : 393 - 394
[28] [18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma
Orevi, Marina
Shamni, Ofer
Zalcman, Nomi
Chicheportiche, Alexandre
Mordechai, Anat
Moscovici, Samuel
Shoshan, Yigal
Shahar, Tal
Charbit, Hanna
Gutreiman, Mijal
Paldor, Iddo
Mishani, Eyal
Lossos, Alexander
Lavon, Iris
NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
[29] 18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy
Mapelli, Paola
Zerbetto, Flavia
Incerti, Elena
Conte, Gian Marco
Bettinardi, Valentino
Fallanca, Federico
Anzalone, Nicoletta
Di Muzio, Nadia
Gianolli, Luigi
Picchio, Maria
CLINICAL NUCLEAR MEDICINE, 2017, 42 (12) : E525 - E526
[30] Demonstration of F-18 FDG PET protocol for imaging neuronal activation: Human motor cortex activation using F-18 FDG PET
Kim, S.
Park, K. W.
Pyun, S. P.
Hwang, Y. M.
Nam, K.
Yeo, J. S.
Choe, J. G.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 254 - 254

← 1 2 3 4 5 →